Mr. Speaker, I actually think the hon. member and I and our government's plan are on the exact same page and the same path forward. The evidence I speak about is the fact that we have an advisory council that is advising us on the best way to implement this and the areas in which we need to act.
This budget builds that foundation, in terms of drug purchasing, to create one negotiator. This in itself will help deal with the issue of multiple provinces and territories, as well as multiple people, negotiating with drug companies. By having one negotiator, we set the foundation in place to then move forward in other areas.
I also spoke about drugs for rare diseases, which can be incredibly difficult to deal with, especially in smaller provinces or provinces with smaller populations. This will allow the federal government to help in that area. Again, this is building on the foundation that will be based on the advisory council's advice. The next report will be coming soon.
However, we were not going to wait for all of the reports. We wanted to build on their recommendations and advice as soon as we could, and that is exactly what this budget does.